fig4

Figure 4. (A) The viability of U251 cells after 12 and 24 h of isocuB treatment (^**P < 0.01, ^***P < 0.001; ^****P < 0.0001 vs. control group); (B) The viability of U87 cells after 24 h of isocuB treatment (^***P < 0.001; ^****P < 0.0001 vs. control group); (C and D) Cell mobility of U251 cells after12, 24 and 36 h of isocuB treatment (^*P < 0.05, ^**P < 0.01, ^***P < 0.001 vs. control group). isocuB: Isocucurbitacin B.